UBE2T is a diagnostic and prognostic biomarker for endometrial cancer
UBE2T is highly expressed in UCEC and suppresses anti-tumor immune responses in UCEC patients. It serves as a key participant in UCEC progression, associated with a range of adverse outcomes, and holds potential as a clinical diagnostic and prognostic biomarker.
Authors
- Bo-Wei Zhao (ORCID: https://orcid.org/0000-0001-8200-6016)
- Jingying Zheng (ORCID: https://orcid.org/0000-0002-7790-4775)
- Longyun Wang
- Yue Wang (ORCID: https://orcid.org/0000-0001-6936-5081)
- Kai Wang (ORCID: https://orcid.org/0000-0002-6151-0034)
- Mengqi Wang
- Zeyu Wang (ORCID: https://orcid.org/0009-0005-0595-6663)
- Shuang Zhang (ORCID: https://orcid.org/0000-0003-4927-7230)
Institutions
- Jilin University (CN)
- Second Affiliated Hospital of Jilin University (CN)
- Third Affiliated Hospital of Zhengzhou University (CN)
- Jilin Agricultural University (CN)
Publication Details
- Journal
- Clinical & Translational Oncology
- Published
- 2024-10-05
- DOI
- https://doi.org/10.1007/s12094-024-03713-z
- Citations
- 6
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 2.51
Funders
- Department of Science and Technology of Jilin Province